Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group-Reference-Cited by-同舟云学术

Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group

Published:2018-10-04 Issue:14 Volume:132 Page:1519-1525
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Eichenauer Dennis A.¹²,Plütschow Annette¹²,Schröder Lena²,Fuchs Michael¹²,Böll Boris¹²,von Tresckow Bastian¹²,Diehl Volker²,Borchmann Peter¹²,Engert Andreas¹²

Affiliation:

1. First Department of Internal Medicine and

2. German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany

Abstract

Key Points Patients with relapsed or refractory NLPHL have a favorable overall prognosis. Treatment of relapsed or refractory NLPHL should be chosen individually.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/132/14/1519/1406927/blood836437.pdf

Reference26 articles.

1. Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management;Eichenauer;Hematology Am Soc Hematol Educ Program,2017

2. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: a retrospective study by the European Society for Blood And Marrow Transplantation-Lymphoma Working Party;Akhtar;Am J Hematol,2018

3. High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma;Akhtar;Ann Hematol,2016

4. High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma;Karuturi;Biol Blood Marrow Transplant,2013

5. Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG);Schulz;Blood,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma;Journal of Clinical Oncology;2024-07-01

2. Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies;Blood;2023-08-10

3. The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology;Virchows Archiv;2023-08-02

4. SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-07

5. Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?;Cancers;2023-06-23